Volume 62, Issue 6, Pages (December 2002)

Slides:

Advertisements

Similar presentations

Renal Stress Testing in the Assessment of Kidney Disease Lakhmir S. Chawla, Claudio Ronco Kidney International Reports Volume 1, Issue 1, Pages (May.

Advertisements

Urine Potassium Excretion, Kidney Failure, and Mortality in CKD

Volume 59, Issue 3, Pages (March 2001)

Volume 67, Pages S1-S7 (June 2005)

Uric Acid and Long-term Outcomes in CKD

Frederik Persson, Peter Rossing Kidney International Supplements

Volume 57, Issue 4, Pages (April 2000)

Renal manifestations in Fabry disease and therapeutic options

Diagnosis and Management of Chronic Kidney Disease

Core Assessment of Predonation Kidney Function: Clarification of the 2017 KDIGO Living Donor Guideline Krista L. Lentine, MD, PhD, Andrew S. Levey, MD,

Blaithin A. McMahon, Patrick Thomas Murray Kidney International

From secondary to primary prevention of progressive renal disease: The case for screening for albuminuria Paul E. De Jong, Barry M. Brenner Kidney International

C-reactive protein and dialysis access

Volume 79, Issue 2, Pages (January 2011)

Volume 67, Issue 5, Pages (May 2005)

A Decade After the KDOQI CKD Guidelines

Prehypertension and chronic kidney disease: the ox or the plow?

Volume 80, Issue 10, Pages (November 2011)

Progression of renal failure and hypertensive nephrosclerosis

Volume 57, Issue 5, Pages (May 2000)

Corrections to "Estimating the glomerular filtration rate from serum creatinine is better than from cystatin C for evaluating risk factors associated.

C-reactive protein and dialysis access

John P. Middleton, Patrick H. Pun Kidney International

Rise or fall of glomerular filtration rate: does it matter?

Yasuhiro Hamada, Masafumi Fukagawa Kidney International

Better nephrology for mice—and man

Effect of Protein Restriction on Serum and Urine Phosphate in the Modification of Diet in Renal Disease (MDRD) Study Britt Newsome, MD, Joachim H. Ix,

Volume 77, Issue 1, Pages 5-6 (January 2010)

Anemia as a risk factor for chronic kidney disease

Comorbidity and confounding in end-stage renal disease

D. Batlle, P. Ramadugu, M.J. Soler Kidney International

Volume 57, Issue 4, Pages (April 2000)

Targets to retard the progression of diabetic nephropathy

Volume 70, Issue 11, Pages (December 2006)

Long-term outcomes in nondiabetic chronic kidney disease

Volume 87, Issue 2, Pages (February 2015)

Dyslipidemia in children with chronic kidney disease

Volume 65, Issue 2, Pages (February 2004)

Volume 70, Issue 12, Pages (December 2006)

Volume 86, Issue 3, Pages (September 2014)

Aggressive blood pressure reduction and renin–angiotensin system blockade in chronic kidney disease: time for re-evaluation? Pantelis A. Sarafidis, Luis.

Fructose intake as a risk factor for kidney stone disease

Volume 65, Issue 3, Pages (March 2004)

Volume 76, Issue 3, Pages (August 2009)

Alfonso M. Cueto-Manzano, Héctor R

Drug Dose Adjustments in Patients With Renal Impairment

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Volume 63, Pages S38-S42 (February 2003)

Kai Singbartl, John A. Kellum Kidney International

Proteinuria and hypertensive nephrosclerosis in African Americans

Methods for guideline development

The global challenge of chronic kidney disease

Volume 68, Issue 2, Pages (August 2005)

Volume 85, Issue 5, Pages (May 2014)

Volume 80, Issue 3, Pages (August 2011)

Volume 76, Issue 7, Pages (October 2009)

Volume 79, Issue 4, Pages (February 2011)

Volume 77, Issue 7, Pages (April 2010)

Clinical benefits of slowing the progression of renal failure

Volume 60, Issue 1, Pages (July 2001)

Volume 80, Issue 10, Pages (November 2011)

Is it the low-protein diet or simply the salt restriction?

Is complement a target for therapy in renal disease?

Fetuin-A is not associated with mortality in chronic kidney disease

Volume 77, Issue 11, Pages (June 2010)

Volume 59, Issue 3, Pages (March 2001)

Volume 53, Issue 5, Pages (May 1998)

Volume 57, Pages S44-S48 (April 2000)

Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies Lei-Shi Li, Zhi-Hong Liu Kidney International

Presentation transcript:

Volume 62, Issue 6, Pages 2208-2215 (December 2002) Serum C-reactive protein and leptin as predictors of kidney disease progression in the Modification of Diet in Renal Disease Study Mark J. Sarnak, Anthony Poindexter, Shin-Ru Wang, Gerald J. Beck, John W. Kusek, Santica M. Marcovina, Tom Greene, Andrew S. Levey Kidney International Volume 62, Issue 6, Pages 2208-2215 (December 2002) DOI: 10.1046/j.1523-1755.2002.00677.x Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 1 (A) Association of the mean glomerular filtration rate (GFR) slope over three years with baseline C-reactive protein (CRP) in Study A. The 25th, 50th and 75th percentiles for C-reactive protein were 0.12, 0.25 and 0.65 mg/dL, respectively. (B) Association of mean GFR slope with baseline CRP in Study B. The 25th, 50th and 75th percentiles for C-reactive protein were 0.09, 0.2 and 0.54 mg/dL, respectively. Kidney International 2002 62, 2208-2215DOI: (10.1046/j.1523-1755.2002.00677.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 2 (A) Association of mean GFR slope over three years with baseline leptin in Study A. The 25th, 50th and 75th percentiles for leptin were 5.1, 9.8 and 18.75 ng/mL, respectively. (B) Association of mean GFR slope with baseline leptin in Study B. The 25th, 50th and 75th percentiles for leptin were 4.1, 7.80 and 18.9 ng/mL, respectively. Kidney International 2002 62, 2208-2215DOI: (10.1046/j.1523-1755.2002.00677.x) Copyright © 2002 International Society of Nephrology Terms and Conditions